Chemical Component Summary

Name4-[(11BETA,17BETA)-17-METHOXY-17-(METHOXYMETHYL)-3-OXOESTRA-4,9-DIEN-11-YL]BENZALDEHYDE OXIME
Identifiers(8S,11R,13S,14S,17S)-11-[4-[(E)-hydroxyiminomethyl]phenyl]-17-methoxy-17-(methoxymethyl)-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
FormulaC28 H35 N O4
Molecular Weight449.582
TypeNON-POLYMER
Isomeric SMILESC[C@]12C[C@@H](C3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@]2(COC)OC)c5ccc(cc5)\C=N\O
InChIInChI=1S/C28H35NO4/c1-27-15-24(19-6-4-18(5-7-19)16-29-31)26-22-11-9-21(30)14-20(22)8-10-23(26)25(27)12-13-28(27,33-3)17-32-2/h4-7,14,16,23-25,31H,8-13,15,17H2,1-3H3/b29-16+/t23-,24+,25-,27-,28+/m0/s1
InChIKeyGJMNAFGEUJBOCE-MEQIQULJSA-N

Chemical Details

Formal Charge0
Atom Count68
Chiral Atom Count5
Bond Count72
Aromatic Bond Count12

Drug Info: DrugBank

DrugBank IDDB06680 
NameAsoprisnil
Groups investigational
DescriptionAsoprisnil (J867) is a selective progesterone receptor modulator. It can be used to treat progesterone sensitive myomata.
SynonymsAsoprisnil
IndicationInvestigated for use/treatment in uterine fibroids.
Categories
  • Amines
  • Estranes
  • Fused-Ring Compounds
  • Hydroxylamines
  • Steroids
CAS number199396-76-4

Drug Targets

NameTarget SequencePharmacological ActionActions
Progesterone receptorMTELKAKGPRAPHVAGGPPSPEVGSPLLCRPAAGPFPGSQTSDTLPEVSA...unknown
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL267431
PubChem 9577221
ChEMBL CHEMBL267431